PSEUDOMONAS AERUGINOSA INFECTION
Clinical trials for PSEUDOMONAS AERUGINOSA INFECTION explained in plain language.
Never miss a new study
Get alerted when new PSEUDOMONAS AERUGINOSA INFECTION trials appear
Sign up with your email to follow new studies for PSEUDOMONAS AERUGINOSA INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug MP101 takes on tough lung infection in early safety trial
Disease control Not yet recruitingThis early-stage study tests a new drug, MP101, given once through a vein alongside standard antibiotics for adults with a severe lung infection from Pseudomonas bacteria. The main goal is to check if MP101 is safe and tolerable. Only 18 people will take part, and the study is no…
Matched conditions: PSEUDOMONAS AERUGINOSA INFECTION
Phase: PHASE1 • Sponsor: MicrobiotiX Co., Ltd • Aim: Disease control
Last updated May 17, 2026 04:34 UTC
-
Personalized antibiotic dosing could save ICU patients
Disease control Not yet recruitingThis study aims to find the best way to give the antibiotic ceftazidime to patients in intensive care with serious infections. Standard dosing often fails to reach effective levels in 40-60% of patients. The researchers will test a personalized dosing plan based on each patient's…
Matched conditions: PSEUDOMONAS AERUGINOSA INFECTION
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Disease control
Last updated May 05, 2026 11:54 UTC